OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing
Yang Pan, John W. Phillips, Beatrice Zhang, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy
Guangyuan Li, Shweta Mahajan, Siyuan Ma, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 730
Open Access | Times Cited: 28

Advances in CAR T cell therapy: antigen selection, modifications, and current trials for solid tumors
Salma Khan, Yeonjoo Choi, Mysore S. Veena, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 3

Tumour-wide RNA splicing aberrations generate actionable public neoantigens
Darwin Kwok, Nicholas Stevers, Iñaki Etxeberría, et al.
Nature (2025)
Open Access | Times Cited: 2

Computational immunogenomic approaches to predict response to cancer immunotherapies
Venkateswar Addala, Felicity Newell, John V. Pearson, et al.
Nature Reviews Clinical Oncology (2023) Vol. 21, Iss. 1, pp. 28-46
Open Access | Times Cited: 34

Defining T cell receptor repertoires using nanovial-based binding and functional screening
Doyeon Koo, Zhiyuan Mao, Robert Dimatteo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 14
Open Access | Times Cited: 13

Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression
Timothy I. Shaw, Jessica Wagner, Liqing Tian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12

Characterization of Tumor Antigens from Multi-omics Data: Computational Approaches and Resources
Yunzhe Wang, James Wengler, Yousheng Fang, et al.
Genomics Proteomics & Bioinformatics (2025)
Open Access | Times Cited: 1

RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets
Yang Pan, Kathryn E. Kadash-Edmondson, Robert Wang, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 268-282
Open Access | Times Cited: 53

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma
Takahide Nejo, Lin Wang, Kevin K. Leung, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8

Steering research on mRNA splicing in cancer towards clinical translation
Olga Anczuków, Frédéric H.‐T. Allain, Brittany Angarola, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 12, pp. 887-905
Closed Access | Times Cited: 6

Molecular mechanisms of non-genetic aberrant peptide production in cancer
Demi Wernaart, Amos Fumagalli, Reuven Agami
Oncogene (2024) Vol. 43, Iss. 27, pp. 2053-2062
Closed Access | Times Cited: 5

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives
Xiaoya Li, Fang Yang, Meijing Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy
Breanna DiAndreth, Pavlo A. Nesterenko, Aaron Winters, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Cancer Immunogenomics Approaches and Applications to Cancer Vaccines
Elizabeth A.R. Garfinkle, Elaine R. Mardis
The Cancer Journal (2025) Vol. 31, Iss. 2
Closed Access

Alternative Splicing: A Key Regulator in T cell Response and Cancer Immunotherapy
C.-C. Yong, Yexin Liang, Minmin Wang, et al.
Pharmacological Research (2025), pp. 107713-107713
Open Access

Alternative Splicing in Lung Adenocarcinoma: From Bench to Bedside
Wenjie Luo, Mingjing Xu, Nathalie Wong, et al.
Cancers (2025) Vol. 17, Iss. 8, pp. 1329-1329
Open Access

Protein isoform-centric therapeutics: expanding targets and increasing specificity
Peter Kjer-Hansen, Tri Giang Phan, Robert J. Weatheritt
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 10, pp. 759-779
Closed Access | Times Cited: 3

Tumor-wide RNA splicing aberrations generate immunogenic public neoantigens
Darwin Kwok, Nicholas Stevers, Takahide Nejo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8

Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates
Franziska Lang, Patrick Sorn, M Suchan, et al.
Bioinformatics Advances (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2

Putatively cancer-specific exon–exon junctions are shared across patients and present in developmental and other non-cancer cells
Julianne K. David, Sean K. Maden, Benjamin R. Weeder, et al.
NAR Cancer (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 14

DIPAN: Detecting personalized intronic polyadenylation derived neoantigens from RNA sequencing data
Xiaochuan Liu, Wen Jin, Dengyi Bao, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2057-2066
Open Access | Times Cited: 1

IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapy
Rawan Shraim, Brian Mooney, Karina L. Conkrite, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

OutSplice: A Novel Tool for the Identification of Tumor-Specific Alternative Splicing Events
Joseph Bendik, Sandhya Kalavacherla, Nicholas J. G. Webster, et al.
BioMedInformatics (2023) Vol. 3, Iss. 4, pp. 853-868
Open Access | Times Cited: 3

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma
Takahide Nejo, Lin Wang, Kevin K. Leung, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top